Enovis (ENOV) Long-Term Deferred Tax (2010 - 2011)
Enovis' (ENOV) quarterly Long-Term Deferred Tax came in at $44.0 million in Q4 2011, down 16.03% year-on-year from $52.4 million in Q4 2010, and down 8.41% on a QoQ basis from $48.0 million in Q3 2011.
Enovis (ENOV) Long-Term Deferred Tax (2010 - 2011) Analysis & Trends
Enovis (ENOV) has 2 years of Long-Term Deferred Tax data on file, last reported at $44.0 million in Q4 2011.
- On a quarterly basis, Long-Term Deferred Tax fell 16.03% year-over-year to $44.0 million in Q4 2011; TTM through Dec 2011 was $44.0 million, a 16.03% decrease from a year earlier, with the FY2011 full-year figure at $44.0 million, down 16.03% from the prior year.
- Long-Term Deferred Tax for Q4 2011 stood at $44.0 million, down from $48.0 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for ENOV reached as high as $52.4 million in Q4 2010 and fell as low as $44.0 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 43.99 Mn |
| Sep 30, 2011 | 48.03 Mn |
| Jul 1, 2011 | 52.12 Mn |
| Dec 31, 2010 | 52.39 Mn |